Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ELONVA 150 MICROGRAMOS SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ELONVA 150 MICROGRAMOS SOLUCION INYECTABLE

Approved

STANDARD

ELONVA 150 MICROGRAMOS SOLUCION INYECTABLE

Organon N.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 7, 2025
Approval ID: d25617e283a433f1
Company: Organon N.V.
Type: Standard

Approval Details

Approval Id: d25617e283a433f1
Drug Cima Aemps Name: ELONVA 150 MICROGRAMOS SOLUCION INYECTABLE
Register Number: 09609002IP
Holder Company Name: Organon N.V.
Marketing Company Name: Abacus Medicine A/S
Authorization Date: 2025-11-07
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 150 microgramos
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Organon N.V.

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 7, 2025

Approval ID

d25617e283a433f1

Type

Standard

Back to CIMA-AEMPS Approvals